JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has begun commercially shipping Bupropion Hydrochloride Extended-Release Tablets, 150 mg, the generic version of Biovail Corporation’s antidepressant Wellbutrin XL® Tablets, pursuant to its March 2007 agreement with Anchen Pharmaceuticals, Inc.
